Mersana Therapeutics (MRSN) Free Cash Flow (2016 - 2025)
Mersana Therapeutics (MRSN) free cash flow from Jun 30, 2016 to Sep 30, 2025. The TTM Mersana Therapeutics (MRSN) free cash flow is -$74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Mersana Therapeutics (MRSN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -22.18% |
| 3 Years TTM | +20.88% |
| 5 Years TTM | +1.14% |
| All Time TTM | +13.56% |
Annual Free Cash Flow change of Mersana Therapeutics (MRSN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$55M | -33.16% |
| 2024 | -$82M | -51.79% |
| 2023 | -$171M | +231.75% |
| 2022 | -$52M | -63.34% |
| 2021 | -$141M | +87.10% |
| 2020 | -$75M | +9.98% |
| 2019 | -$68M | +20.78% |
| 2018 | -$57M | +29.14% |
| 2017 | -$44M | -243.63% |
| 2016 | $31M | -397.37% |
| 2015 | -$10M | N/A |
Comparison Mersana Therapeutics (MRSN) five years free cash flow CAGR with competitors
Mersana Therapeutics (MRSN) five years free cash flow CAGR is 1.15%.